Common heart procedure poses kidney risk: can a diabetes pill be the shield?
NCT ID NCT06491953
Summary
This study is testing if a type of diabetes medication, called SGLT2 inhibitors, can prevent kidney damage in heart patients. The kidney damage can sometimes happen after patients receive a special dye during common heart procedures like angioplasty. Researchers will enroll 3600 patients with acute coronary syndrome to see if taking this medication reduces the risk of this specific kidney injury.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, China
Conditions
Explore the condition pages connected to this study.